Which has higher valuation and earnings, PHR or AMWL?

Phreesia has higher revenue and earnings than American Well. American Well is trading at a lower price-to-earnings ratio than Phreesia, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Phreesia $480.59M 1.54 $2.31M $0.15 79.60 American Well $249.32M 0.81 -$95.70M -$4.77 N/A

Is PHR or AMWL more profitable?

Phreesia has a net margin of 1.85% compared to American Well's net margin of -35.75%. Phreesia's return on equity of 5.13% beat American Well's return on equity. Company Net Margins Return on Equity Return on Assets Phreesia 1.85% 5.13% 3.12% American Well -35.75% -30.12% -22.30%

Which has stronger valuation & earnings, AMWL or CTEV?

American Well has higher earnings, but lower revenue than Claritev. American Well is trading at a lower price-to-earnings ratio than Claritev, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio American Well $249.32M 0.81 -$95.70M -$4.77 N/A Claritev $965.41M 0.71 -$284.28M -$17.01 N/A

Is AMWL or CTEV more profitable?

Claritev has a net margin of -28.46% compared to American Well's net margin of -35.75%. Claritev's return on equity of 0.00% beat American Well's return on equity. Company Net Margins Return on Equity Return on Assets American Well -35.75% -30.12% -22.30% Claritev -28.46% N/A -5.76%

Do analysts rate AMWL or MDRX?

American Well currently has a consensus target price of $9.50, indicating a potential downside of 22.26%. Given American Well's stronger consensus rating and higher probable upside, research analysts plainly believe American Well is more favorable than Veradigm. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score American Well 1 Sell rating(s) 5 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Veradigm 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Which has higher valuation & earnings, AMWL or MDRX?

Veradigm has higher revenue and earnings than American Well. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio American Well $249.32M 0.81 -$95.70M -$4.77 N/A Veradigm $1.53B 0.39 N/A N/A N/A

American Well (AMWL) Competitors

$12.18 +0.21 (+1.75%)

As of 03:07 PM Eastern

Compare

AMWL vs. PHR, SOPH, CTEV, MDRX, and WEAV

Should you buy American Well stock or one of its competitors? American Well's main competitors and comparable companies include Phreesia (PHR), SOPHiA GENETICS (SOPH), Claritev (CTEV), Veradigm (MDRX), and Weave Communications (WEAV). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare technology" industry.

How does American Well compare to Phreesia?

Phreesia (NYSE:PHR) and American Well (NYSE:AMWL) are both small-cap healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, profitability, institutional ownership, media sentiment, dividends, earnings, valuation and risk.

In the previous week, Phreesia had 9 more articles in the media than American Well. MarketBeat recorded 9 mentions for Phreesia and 0 mentions for American Well. Phreesia's average media sentiment score of 1.16 beat American Well's score of 1.00 indicating that Phreesia is being referred to more favorably in the media.

Company	Overall Sentiment
Phreesia	Positive
American Well	Positive

Phreesia has higher revenue and earnings than American Well. American Well is trading at a lower price-to-earnings ratio than Phreesia, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Phreesia	$480.59M	1.54	$2.31M	$0.15	79.60
American Well	$249.32M	0.81	-$95.70M	-$4.77	N/A

92.1% of Phreesia shares are owned by institutional investors. Comparatively, 56.1% of American Well shares are owned by institutional investors. 5.2% of Phreesia shares are owned by company insiders. Comparatively, 12.8% of American Well shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Phreesia has a beta of 0.85, meaning that its stock price is 15% less volatile than the broader market. Comparatively, American Well has a beta of 1.68, meaning that its stock price is 68% more volatile than the broader market.

Phreesia currently has a consensus price target of $16.65, indicating a potential upside of 39.42%. American Well has a consensus price target of $9.50, indicating a potential downside of 22.26%. Given Phreesia's stronger consensus rating and higher probable upside, analysts clearly believe Phreesia is more favorable than American Well.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Phreesia	1 Sell rating(s)	9 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.42
American Well	1 Sell rating(s)	5 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Phreesia has a net margin of 1.85% compared to American Well's net margin of -35.75%. Phreesia's return on equity of 5.13% beat American Well's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Phreesia	1.85%	5.13%	3.12%
American Well	-35.75%	-30.12%	-22.30%

Summary

Phreesia beats American Well on 14 of the 16 factors compared between the two stocks.

How does American Well compare to SOPHiA GENETICS?

SOPHiA GENETICS (NASDAQ:SOPH) and American Well (NYSE:AMWL) are both small-cap healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, profitability, analyst recommendations, institutional ownership, earnings, risk, media sentiment and valuation.

31.6% of SOPHiA GENETICS shares are owned by institutional investors. Comparatively, 56.1% of American Well shares are owned by institutional investors. 4.9% of SOPHiA GENETICS shares are owned by insiders. Comparatively, 12.8% of American Well shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

American Well has a net margin of -35.75% compared to SOPHiA GENETICS's net margin of -93.86%. American Well's return on equity of -30.12% beat SOPHiA GENETICS's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
SOPHiA GENETICS	-93.86%	-132.47%	-45.97%
American Well	-35.75%	-30.12%	-22.30%

SOPHiA GENETICS has a beta of 0.96, meaning that its stock price is 4% less volatile than the broader market. Comparatively, American Well has a beta of 1.68, meaning that its stock price is 68% more volatile than the broader market.

In the previous week, SOPHiA GENETICS had 17 more articles in the media than American Well. MarketBeat recorded 17 mentions for SOPHiA GENETICS and 0 mentions for American Well. American Well's average media sentiment score of 1.00 beat SOPHiA GENETICS's score of 0.65 indicating that American Well is being referred to more favorably in the news media.

Company	Overall Sentiment
SOPHiA GENETICS	Positive
American Well	Positive

SOPHiA GENETICS has higher earnings, but lower revenue than American Well. SOPHiA GENETICS is trading at a lower price-to-earnings ratio than American Well, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
SOPHiA GENETICS	$77.27M	8.91	-$79M	-$1.15	N/A
American Well	$249.32M	0.81	-$95.70M	-$4.77	N/A

SOPHiA GENETICS presently has a consensus target price of $10.00, indicating a potential upside of 21.80%. American Well has a consensus target price of $9.50, indicating a potential downside of 22.26%. Given SOPHiA GENETICS's stronger consensus rating and higher possible upside, analysts plainly believe SOPHiA GENETICS is more favorable than American Well.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
SOPHiA GENETICS	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
American Well	1 Sell rating(s)	5 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Summary

American Well beats SOPHiA GENETICS on 9 of the 16 factors compared between the two stocks.

How does American Well compare to Claritev?

American Well (NYSE:AMWL) and Claritev (NYSE:CTEV) are both small-cap healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, analyst recommendations, valuation, institutional ownership, media sentiment, dividends, earnings and risk.

56.1% of American Well shares are held by institutional investors. Comparatively, 87.2% of Claritev shares are held by institutional investors. 12.8% of American Well shares are held by insiders. Comparatively, 7.4% of Claritev shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

American Well currently has a consensus price target of $9.50, indicating a potential downside of 22.26%. Claritev has a consensus price target of $44.83, indicating a potential upside of 11.03%. Given Claritev's stronger consensus rating and higher possible upside, analysts clearly believe Claritev is more favorable than American Well.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
American Well	1 Sell rating(s)	5 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Claritev	1 Sell rating(s)	2 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.56

Claritev has a net margin of -28.46% compared to American Well's net margin of -35.75%. Claritev's return on equity of 0.00% beat American Well's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
American Well	-35.75%	-30.12%	-22.30%
Claritev	-28.46%	N/A	-5.76%

In the previous week, Claritev had 10 more articles in the media than American Well. MarketBeat recorded 10 mentions for Claritev and 0 mentions for American Well. Claritev's average media sentiment score of 1.37 beat American Well's score of 1.00 indicating that Claritev is being referred to more favorably in the news media.

Company	Overall Sentiment
American Well	Positive
Claritev	Positive

American Well has higher earnings, but lower revenue than Claritev. American Well is trading at a lower price-to-earnings ratio than Claritev, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
American Well	$249.32M	0.81	-$95.70M	-$4.77	N/A
Claritev	$965.41M	0.71	-$284.28M	-$17.01	N/A

American Well has a beta of 1.68, meaning that its share price is 68% more volatile than the broader market. Comparatively, Claritev has a beta of 0.74, meaning that its share price is 26% less volatile than the broader market.

Summary

Claritev beats American Well on 11 of the 16 factors compared between the two stocks.

How does American Well compare to Veradigm?

American Well (NYSE:AMWL) and Veradigm (NASDAQ:MDRX) are both small-cap healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, earnings, media sentiment, analyst recommendations, valuation, profitability, dividends and risk.

Veradigm has higher revenue and earnings than American Well.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
American Well	$249.32M	0.81	-$95.70M	-$4.77	N/A
Veradigm	$1.53B	0.39	N/A	N/A	N/A

Veradigm has a net margin of 0.00% compared to American Well's net margin of -35.75%. Veradigm's return on equity of 0.00% beat American Well's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
American Well	-35.75%	-30.12%	-22.30%
Veradigm	N/A	N/A	N/A

In the previous week, American Well's average media sentiment score of 1.00 beat Veradigm's score of 0.00 indicating that American Well is being referred to more favorably in the media.

Company	Overall Sentiment
American Well	Positive
Veradigm	Neutral

56.1% of American Well shares are held by institutional investors. 12.8% of American Well shares are held by company insiders. Comparatively, 2.3% of Veradigm shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

American Well has a beta of 1.68, suggesting that its share price is 68% more volatile than the broader market. Comparatively, Veradigm has a beta of 0.54, suggesting that its share price is 46% less volatile than the broader market.

American Well currently has a consensus target price of $9.50, indicating a potential downside of 22.26%. Given American Well's stronger consensus rating and higher probable upside, research analysts plainly believe American Well is more favorable than Veradigm.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
American Well	1 Sell rating(s)	5 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Veradigm	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Summary

American Well beats Veradigm on 8 of the 13 factors compared between the two stocks.

How does American Well compare to Weave Communications?

American Well (NYSE:AMWL) and Weave Communications (NYSE:WEAV) are both small-cap healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, earnings, analyst recommendations, dividends, profitability, media sentiment, risk and valuation.

American Well has a beta of 1.68, meaning that its share price is 68% more volatile than the broader market. Comparatively, Weave Communications has a beta of 1.67, meaning that its share price is 67% more volatile than the broader market.

Weave Communications has a net margin of -7.97% compared to American Well's net margin of -35.75%. Weave Communications' return on equity of -21.14% beat American Well's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
American Well	-35.75%	-30.12%	-22.30%
Weave Communications	-7.97%	-21.14%	-8.41%

In the previous week, Weave Communications had 4 more articles in the media than American Well. MarketBeat recorded 4 mentions for Weave Communications and 0 mentions for American Well. Weave Communications' average media sentiment score of 1.59 beat American Well's score of 1.00 indicating that Weave Communications is being referred to more favorably in the news media.

Company	Overall Sentiment
American Well	Positive
Weave Communications	Very Positive

Weave Communications has lower revenue, but higher earnings than American Well. Weave Communications is trading at a lower price-to-earnings ratio than American Well, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
American Well	$249.32M	0.81	-$95.70M	-$4.77	N/A
Weave Communications	$239.02M	2.44	-$28.05M	-$0.25	N/A

56.1% of American Well shares are owned by institutional investors. Comparatively, 86.8% of Weave Communications shares are owned by institutional investors. 12.8% of American Well shares are owned by insiders. Comparatively, 16.4% of Weave Communications shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

American Well presently has a consensus price target of $9.50, indicating a potential downside of 22.26%. Weave Communications has a consensus price target of $7.84, indicating a potential upside of 7.40%. Given Weave Communications' stronger consensus rating and higher possible upside, analysts clearly believe Weave Communications is more favorable than American Well.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
American Well	1 Sell rating(s)	5 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Weave Communications	1 Sell rating(s)	5 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.13

Summary

Weave Communications beats American Well on 13 of the 16 factors compared between the two stocks.

Get American Well News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AMWL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

AMWL vs. The Competition

Export

Metric	American Well	Healthcare Technology Industry	Healthcare Sector	NYSE Exchange
Market Cap	$202.24M	$1.76B	$7.13B	$23.83B
Dividend Yield	N/A	4.68%	2.54%	3.72%
P/E Ratio	-2.56	21.46	272.59	29.48
Price / Sales	0.81	83.34	618.94	19.36
Price / Cash	N/A	31.93	28.78	19.75
Price / Book	0.82	6.18	11.06	4.77
Net Income	-$95.70M	-$26.60M	$3.47B	$1.07B
7 Day Performance	5.57%	1.82%	-0.83%	-1.88%
1 Month Performance	13.49%	14.04%	7.15%	0.66%
1 Year Performance	74.95%	-15.69%	24.62%	11.93%

American Well Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
AMWL American Well	2.1476 of 5 stars	$12.18 +1.8%	$9.50 -22.0%	+71.5%	$201.58M	$249.32M	N/A	1,040	Positive News
PHR Phreesia	4.4073 of 5 stars	$12.16 -0.4%	$16.65 +36.9%	-61.6%	$751.55M	$480.59M	81.06	1,789	News Coverage Positive News Upcoming Earnings Analyst Forecast
SOPH SOPHiA GENETICS	3.1181 of 5 stars	$8.18 -2.7%	$10.00 +22.3%	+142.8%	$685.80M	$77.27M	N/A	520
CTEV Claritev	2.5964 of 5 stars	$40.37 +1.4%	$44.83 +11.1%	-42.5%	$684.27M	$965.41M	N/A	3,000	News Coverage Positive News Insider Trade
MDRX Veradigm	N/A	$4.88 +1.6%	N/A	-2.0%	$596.82M	$1.53B	23.25	8,000

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:AMWL) was last updated on 9/1/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

American Well (AMWL) Competitors

AMWL vs. PHR, SOPH, CTEV, MDRX, and WEAV

How does American Well compare to Phreesia?

Summary

How does American Well compare to SOPHiA GENETICS?

Summary

How does American Well compare to Claritev?

Summary

How does American Well compare to Veradigm?

Summary

How does American Well compare to Weave Communications?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

AMWL vs. The Competition

American Well Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

American Well (AMWL) Competitors

AMWL vs. PHR, SOPH, CTEV, MDRX, and WEAV

How does American Well compare to Phreesia?

Does the media prefer PHR or AMWL?

Which has higher valuation and earnings, PHR or AMWL?

Do insiders and institutionals believe in PHR or AMWL?

Which has more risk & volatility, PHR or AMWL?

Do analysts recommend PHR or AMWL?

Is PHR or AMWL more profitable?

Summary

How does American Well compare to SOPHiA GENETICS?

Do institutionals & insiders believe in SOPH or AMWL?

Is SOPH or AMWL more profitable?

Which has more risk and volatility, SOPH or AMWL?

Does the media prefer SOPH or AMWL?

Which has preferable earnings & valuation, SOPH or AMWL?

Do analysts recommend SOPH or AMWL?

Summary

How does American Well compare to Claritev?

Do institutionals and insiders believe in AMWL or CTEV?

Do analysts recommend AMWL or CTEV?

Is AMWL or CTEV more profitable?

Does the media prefer AMWL or CTEV?

Which has stronger valuation & earnings, AMWL or CTEV?

Which has more volatility and risk, AMWL or CTEV?

Summary

How does American Well compare to Veradigm?

Which has higher valuation & earnings, AMWL or MDRX?

Is AMWL or MDRX more profitable?

Does the media favor AMWL or MDRX?

Do insiders and institutionals have more ownership in AMWL or MDRX?

Which has more risk and volatility, AMWL or MDRX?

Do analysts rate AMWL or MDRX?

Summary

How does American Well compare to Weave Communications?

Which has more risk & volatility, AMWL or WEAV?

Is AMWL or WEAV more profitable?

Does the media favor AMWL or WEAV?

Which has preferable earnings and valuation, AMWL or WEAV?

Do insiders & institutionals have more ownership in AMWL or WEAV?

Do analysts rate AMWL or WEAV?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

AMWL vs. The Competition

American Well Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools